Perfil
Thomas L.
Gutshall is the founder of CEPHEID, which was founded in 1996.
He served as Chairman from 2002 to 2013.
Currently, he holds director positions at Profusa, Inc., Pacific Medical Research Foundation, Silver Bullet Therapeutics, Inc., and is an advisor at 1Flourish Capital LLC.
Previously, he served as a Director at CV Therapeutics, Inc. from 1994 to 2009, and as a Director at Metrika, Inc. and Satoris, Inc. He also served as Executive Vice President at Syntex Corp.
from 1989 to 1994.
Mr. Gutshall received his undergraduate degree from the University of Delaware in 1960.
Cargos activos de Thomas L. Gutshall
| Empresas | Cargo | Inicio |
|---|---|---|
Pacific Medical Research Foundation | Director/Miembro de la Junta | - |
Profusa, Inc. (California)
Profusa, Inc. (California) Electronic Equipment/InstrumentsElectronic Technology Manufactures tissue integrated biosensors for continuous monitoring of body chemistries | Director/Miembro de la Junta | 01/01/2012 |
Silver Bullet Therapeutics, Inc.
Silver Bullet Therapeutics, Inc. BiotechnologyHealth Technology Develops antimicrobial coating based on proprietary silver ionization technology for medical devices | Director/Miembro de la Junta | - |
1Flourish Capital LLC
1Flourish Capital LLC Investment ManagersFinance 1Flourish Capital invests in companies located in the United States. The firm targets companies operating in the field of the deep technology such as physical AI, defense technology and dual-use innovation sector. It provides financing for pre-seed, seed and early-stage capital requirements. | Consultor / Asesor | - |
Antiguos cargos conocidos de Thomas L. Gutshall.
| Empresas | Cargo | Fin |
|---|---|---|
Satoris, Inc.
Satoris, Inc. Miscellaneous Commercial ServicesCommercial Services Develops tests for neurological diseases | Director/Miembro de la Junta | 01/01/2011 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Director/Miembro de la Junta | 17/04/2009 |
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Corporate Officer/Principal | 01/12/1994 |
Metrika, Inc.
Metrika, Inc. BiotechnologyHealth Technology Manufactures and markets diabetes monitoring products | Director/Miembro de la Junta | - |
| CEPHEID | Director Ejecutivo | 22/04/2002 |
Formación de Thomas L. Gutshall.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 10 |
|---|---|
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
CEPHEID
CEPHEID Medical SpecialtiesHealth Technology Develops, manufactures and markets molecular diagnostic systems | Health Technology |
Metrika, Inc.
Metrika, Inc. BiotechnologyHealth Technology Manufactures and markets diabetes monitoring products | Health Technology |
Satoris, Inc.
Satoris, Inc. Miscellaneous Commercial ServicesCommercial Services Develops tests for neurological diseases | Commercial Services |
Profusa, Inc. (California)
Profusa, Inc. (California) Electronic Equipment/InstrumentsElectronic Technology Manufactures tissue integrated biosensors for continuous monitoring of body chemistries | Electronic Technology |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacific Medical Research Foundation | |
Silver Bullet Therapeutics, Inc.
Silver Bullet Therapeutics, Inc. BiotechnologyHealth Technology Develops antimicrobial coating based on proprietary silver ionization technology for medical devices | Health Technology |
1Flourish Capital LLC
1Flourish Capital LLC Investment ManagersFinance 1Flourish Capital invests in companies located in the United States. The firm targets companies operating in the field of the deep technology such as physical AI, defense technology and dual-use innovation sector. It provides financing for pre-seed, seed and early-stage capital requirements. | Finance |
- Bolsa de valores
- Insiders
- Thomas L. Gutshall
















